
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Zhejiang Cancer Hospital)"
Count: 271
Selected: 0
NCT ID | Title |
---|
NCT02385136 | Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases | ||
NCT02992067 | CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer | ||
NCT01258192 | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients | ||
NCT01915134 | Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma | ||
NCT05461690 | Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency | ||
NCT01536223 | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma | ||
NCT02702323 | Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study | ||
NCT02597868 | A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) | ||
NCT04189094 | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC | ||
NCT05794841 | Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract | ||
NCT04543890 | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | ||
NCT05651802 | PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients | ||
NCT05126160 | Immune Score Based Radiomics in Nasopharyngeal Carcinoma | ||
NCT03015727 | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma | ||
NCT05007587 | Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC | ||
NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | ||
NCT05183958 | A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer | ||
NCT05896059 | A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC | ||
NCT05856383 | Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC | ||
NCT05813626 | Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | ||
NCT05705583 | A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma | ||
NCT05669807 | Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer | ||
NCT05669092 | A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status | ||
NCT05652192 | SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC | ||
NCT05617469 | DLCS for Predicting Neoadjuvant Chemotherapy Response | ||
NCT05596071 | Whether Opioids Are Factor That Induced POD? | ||
NCT05564897 | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer | ||
NCT05559775 | A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy | ||
NCT05557578 | GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence | ||
NCT05550090 | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC | ||
NCT05544149 | TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors | ||
NCT05528367 | Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | ||
NCT05514275 | Radiotherapy Combined With Endostatin and Capecitabine for NPC | ||
NCT05507411 | Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC | ||
NCT05502458 | Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor | ||
NCT05489926 | A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure | ||
NCT05480189 | Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study | ||
NCT05468671 | Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy | ||
NCT05448638 | Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery | ||
NCT05410444 | The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer | ||
NCT05387044 | SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors | ||
NCT05385809 | A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer | ||
NCT05322499 | Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer | ||
NCT05298319 | The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy | ||
NCT05290090 | ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL | ||
NCT05269056 | Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics | ||
NCT05247619 | A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer | ||
NCT05242861 | Retrospective Study of Brachytherapy | ||
NCT05234905 | H101 Combined With Camrelizumab for Recurrent Cervical Cancer | ||
NCT05232552 | Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma |